Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001167496-26-000005

President and CEO acquired 180,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SIEGALL CLAY B · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-23 Grant or award : show line 1 in the form +180,000 870,704 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-23 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +360,000 360,000 D
Loading xslF345X06/form4-07272026_040701.xml…